BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
56.63
+1.42 (2.57%)
Oct 22, 2026, 4:00 PM EDT - Market closed
BioMarin Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Reiterates $124 → $122 | Buy | Reiterates | $124 → $122 | +115.43% | Oct 21, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $90 | Buy | Maintains | $90 | +58.93% | Oct 21, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $120 | Buy | Maintains | $120 | +111.90% | Oct 21, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $86 | Buy | Maintains | $86 | +51.86% | Oct 20, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $86 → $87 | Buy | Reiterates | $86 → $87 | +53.63% | Oct 20, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $80 | Buy | Reiterates | $80 | +41.27% | Oct 20, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $114 | Buy | Maintains | $114 | +101.31% | Oct 16, 2026 |
| UBS | UBS | Buy Reiterates $114 → $88 | Buy | Reiterates | $114 → $88 | +55.39% | Oct 15, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.